4.7 Letter

Comment on: Concerns of using sialidase fusion protein as an experimental drug to combat seasonal and pandemic influenza

Related references

Note: Only part of the references are listed.
Article Infectious Diseases

Concerns of using sialidase fusion protein as an experimental drug to combat seasonal and pandemic influenza

Hong Zhang

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)

Article Microbiology

Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection

MP Malakhov et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)

Article Physiology

Involvement of the platelet-activating factor receptor in host defense against Streptococcus pneumoniae during postinfluenza pneumonia

KF van der Sluijs et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2006)

Article Multidisciplinary Sciences

Influenza virus entry and infection require host cell N-linked glycoprotein

VC Chu et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Article Biochemistry & Molecular Biology

Influenza virus infection of desialylated cells

SJ Stray et al.

GLYCOBIOLOGY (2000)